Long-term NO synthase inhibition affects heart weight and geometry of coronary and carotid arteries

Physiological Research

Volumn 45, Issue 5, 1996, Pages 361-367

  Kristek, F ^a   Gerova M ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

artery; cardiac hypertrophy; nitric oxide; remodelling

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY; ENZYME INHIBITION; HEART HYPERTROPHY; HEART RATE; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN WEIGHT; RAT; ULTRASTRUCTURE;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CAROTID ARTERIES; CORONARY VESSELS; ENZYME INHIBITORS; HEART; HEART RATE; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ORGAN SIZE; RATS; RATS, WISTAR;

EID: 0029809924     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ARNAL J.F., EL AMRANI A.I., CHATELLIER G., MENARD J., MICHEL J.B.: Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22: 380 - 387, 1993.
2. ARNAL J.F., YAMIN J., DOCKERY S., HARRISON D.G.: Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am. J. Physiol. 267: C1381 - C1388, 1994.
3. BAUMBACH G.L., HEISTAD D.D.: Remodeling of cerebral arterioles in chronic hypertension. Hypertension 13: 968 - 972, 1989.
4. BAYLIS C., MITRUKA B., DENG A.: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 90: 278 - 281, 1992.
5. BERNÁTOVÁ I., PECHÁŇOVÁ O.: Experimental NO-deficient hypertension: metabolic changes in rats. Pflügers Arch. 430: R120, 1995.
6. BERNÁTOVÁ I., PECHÁŇOVÁ O., ŠIMKO F.: Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Physiol. Res. 45: 311 - 316, 1996.
7. BRADY A.J., WARREN J.B., POOLE-WILSON P.A., WILLIAMS T.J., HARDING S.E.: Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265: H176 - H182, 1993.
8. CORNWELL T.L., ARNOLD E., BOERTH N.J., LINCOLN T.M.: Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 267: C1405 - C1413, 1994.
9. DANANBERG J., SIDER R.S., GREKIN R.J.: Sustained hypertension induced by orally administered nitro-L-arginine. Hypertension 21: 39 - 363, 1993.
10. DELACRETAZ E., HAYOZ D., OSTERHELD M.C., GENTON C.Y., BRUNNER H.R., WAEBER B.: Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats. Hypertension 23: 967 - 970, 1994.
11. DUNN W.R., WILSON V.G.: No evidence for vascular remodeling in an L-NAME-induced model of hypertension. Abstracts of the XXXII Congress IUPS, Glasgow, 1993, pp. 109 - 110.
12. FINKEL M.S., ODDIS C.V., MAYER O.H., HATTLER B.G., SIMMONS R.L.: Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J. Pharmacol. Exp. Ther. 272: 945 - 952, 1995.
13. GARG U.C., HASSID A.: Nitric oxide generating vasodilators and 8-bromo cyclic GMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774 - 1777, 1989.
14. GEROVÁ M., PECHÁŇOVÁ O., STOEV V., KITTOVÁ M., BERNÁTOVÁ I.: Protein metabolism in coronary wall affected by cardiac load. Cell. Mol. Biol. Res. 40: 123 - 128, 1994.
15. GEROVÁ M., MAŠANOVÁ C., PAVLÁSEK J.: Inhibition of NO synthase in the posterior hypothalamus increases blood pressure in the rat. Physiol. Res. 44: 131 - 134, 1995.
16. JOVER B., HERIZI A., VENTRE F., DUPONT M., MIMRAN A.: Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 21: 944 - 948, 1993.
17. KENNEDY R.H., HICKS K.K., BRIAN J.E., SEIFEN E.: Nitric oxide has no chronotropic effect in right atria isolated from rat heart. Eur. J. Pharmacol.: 255: 149 - 156, 1994.
18. G-methyl-L-arginine in chronically instrumented conscious dogs. J. Appl. Physiol. 77: 471 - 475, 1994.
19. LEW M.J., ANGUS J.A..: Wall thickness to lumen diameter ratios of arteries from SHR and WKY: comparison of pressurized and wire-mounted preparations. J. Vasc. Res. 29: 435 - 442, 1992.
20. MORTON J.J., BEATTIE E.C., SPEIRS A., GULLIVER F.: Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J. Hypertens. 11: 1083 - 1088, 1993.
21. NAKAKI T., NAKAYAMA M., KATO R.: Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur. J. Pharmacol. 189: 347 - 353, 1990.
22. OWENS G., SCHWARTZ S.: Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ. Res. 53: 491 - 501, 1993.
23. POLLOCK D.M., POLAKOWSKI J.S., DIVISH B.J., OPGENORTH T.J.: Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 21: 660 - 666, 1993.
24. REES D.D., PALMER R.M.J., SCHULZ R., HUDSON H.F., MONCADA S.: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101: 746 - 752, 1990.
25. RIBEIRO M.O., ANTUNES E., DE NUCCI G., LOVISOLO S.M., ZATZ R.: Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20: 298 - 303, 1992.
26. WEYRICH A.S., MA X.-L., BUERKE M., MUROHARA T., ARMSTEAD V.E., LEFER A.M., NICOLAS J.M., THOMAS A.P., LEFER D.J., VINTEN-JOHANSEN J.: Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ. Res. 75: 692 - 700, 1994.